Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study

BACKGROUND: Pirfenidone is an anti-fibrotic agent shown to slow the progression of idiopathic pulmonary fibrosis (IPF). However, its effectiveness in association with serological autoimmune features in IPF remains unclear. METHODS: We retrospectively reviewed the medical records of patients with IPF...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Myung Jin, Lee, Sang Hoon, Jung, Ji Ye, Kang, Young Ae, Park, Moo Suk, Kim, Young Sam, Chang, Joon, Kim, Song Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091553/
https://www.ncbi.nlm.nih.gov/pubmed/33941141
http://dx.doi.org/10.1186/s12890-021-01516-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091553/
https://www.ncbi.nlm.nih.gov/pubmed/33941141
http://dx.doi.org/10.1186/s12890-021-01516-4

Ejemplares similares